JPRN-UMIN000001546
Unknown
未知
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on macular edema secondary to branch retinal vein occlusion - Comparative study of Be and TA on BRVO
Shiga University of Medical Science, department of Ophthalmology0 sites60 target enrollmentDecember 2, 2008
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Macular edema secondary to branch retinal vein occlusion
- Sponsor
- Shiga University of Medical Science, department of Ophthalmology
- Enrollment
- 60
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •glaucoma ocular pressure more than 21 mmHg inflammation disease diabetic retinopathy history of steroid therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with Central Retinal Vein Occlusion : A Randomized Clinical Trialthe efficacy of triamcinolone and bevacizumabwas measured in patients with Central Retinal Vein OcclusionBevacizumab,Intravitreal Injections,Retinal Vein Occlusion,TriamcinoloneTCTR20170612005rmia university of medical sciences90
Completed
Phase 3
Comparison of intravitreal Bevacizumab (Avastin) injection alone or in combination with Diclofenac in the treatment of diabetic macular edemaDiabetic retinopathy.Diabetic retinopathyIRCT201512144786N3Isfahan University of Medical Sciences68
Active, not recruiting
Phase 1
Comparison of Combined Therapy of Intravitreal Injection of Bevacizumab and Pegaptanib versus Mono-therapy (The MAAM Study) - MAAM-StudyEUCTR2006-001389-18-ATudwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery60
Recruiting
Phase 1
Comparison of the effect of intravitreal injection of bevacizumab (Stevenet) alone with intravitreal injection of bevacizumab and triamcinolone in the treatment of diabetic macular edema with a thickness greater than 500 microns in patientsIRCT20211130053229N1Kerman University of Medical Sciences70
Recruiting
Phase 3
The Comparison of Efficacy Between Iranian Made Ranibizumab and Imported Ranibizumab in Diabetic Patients with Macular EdemaIRCT20170303032845N1Aracell zist daru154